TESTIMONIALS (Publicity)

Dr Salansky's Research involving sophisticated light therapy (LE P) has shown good results, especially for the type of RSI called carpal tunnel syndrome

T. Wong, Toronto Star

TORONTO - Carpal tunnel syndrome (CTS) sufferers may be able to avoid surgery.
Dr. N. Salansky found an effective low energy photon (LEP) therapy for CTS. 50 patients treated with LEP were free of symptoms for up to 18 months.

Nancy Deutsh, Family Practice

Low energy photon therapy to treat Chronic & Recalcitrant Ulcers. This treatment developed by Dr. N. Salansky heals chronic ulcers even when skin grafts have failed. Success of this therapy will result in earlier discharge from hospitals for patients with Ulcers and as it was shown in New Brunswick, treatment could be performed at home.

Marvin Ross, Dermatology times of Canada ,
Wound Care

Jim Polaski was loosing hope. It had been more than 10 years since a burning red dot on his leg begun spreading. His doctors in Chicago had a name for the skin disease - pyoderma but what they didn't was a treatment that worked. Through internet Jim found Dr. Norman Salansky, LEPT technology and under IMI experts supervision got the treatment at Scarborough General Hospital (Toronto, Canada). Within two weeks of beginning treatment there, Polaski's agony eased, and his skin started to heal.

Daily Progress, USA

Low energy photon therapy (LEPT) is a non-invasive treatment that utilizes red and infrared light to promote and speed the healing process for a wide range of conditions such as tennis elbow, tendinitis, whiplash, strains and sprains. Crush injuries, contusions, strains and sprains, healing with minimal bruising

J. Foster, The Langley Times

NEW IN MEDICINE
A new treatment for carpal tunnel syndrome, a repetitive strain injury affecting the hands, appears to be highly effective. It uses red and infrared light directed to the skin. In a Toronto pilot study of .21 patients, aged 28 to 66, suffering chronic, painful carpal tunnel syndrome, 15 were freed of symptoms and able to return to their regular work. Two others obtained partial relief. Prof. Salansky Developed this technology at IMI, Inc.

Marilyn Dunlop, Toronto